The extracellular matrix in multiple sclerosis lesions

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 3, 1998, Pages 205-217

  Sobel, Raymond A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axon regeneration; Endothelial cells; Extracellular matrix; Glia; Inflammatory cells; Integrins; Multiple sclerosis

Indexed keywords

BLOOD CLOTTING FACTOR; CELL RECEPTOR; GLYCOPROTEIN; LAMININ; MEMBRANE PROTEIN; PROTEINASE; PROTEOGLYCAN; SCLEROPROTEIN; TENASCIN; THROMBOMODULIN; THROMBOPLASTIN; THROMBOSPONDIN;

BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; DEMYELINATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LEUKOCYTE MIGRATION; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; WHITE MATTER;

EID: 0031942524     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199803000-00001     Document Type: Review

References (177)

1. Juliano RL, Haskill S. Minireview: Signal transduction from the extracellular matrix. J Cell Biol 1993;120:577-85
2. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995;268:233-40
3. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: Emerging paradigms of signal transduction. Ann Rev Cell Dev Biol 1995; 11:549-99
4. Adams JC. Cell adhesion-spreading frontiers, intricate insights. Trends Cell Biol 1997;7:107-10
5. Weller RO, Kida S, Zhang E-T. Pathways of fluid drainage from the brain - morphological aspects and immunological significance in rat and man. Brain Pathol 1992;2:277-84
6. Cserr HF, Knopf PM. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view. Immunol Today 1995;13:507-12
7. Rutka JT, Apodaca G, Stern R, Rosenblum M. The extracellular matrix of the central and peripheral nervous system: Structure and function. J Neurosurg 1988;69:155-70
8. Sanes JR. Extracellular matrix molecules that influence neural development. Ann Rev Neurosci 1989;12:491-516
9. Reichardt LF, Tomaselli KJ. Extracellular matrix molecules and their receptors: Functions in neural development. Ann Rev Neurosci 1991;14:531-70
10. Venstrom KA, Reichardt LF. Extracellular matrix 2: Role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 1993;7:996-1003
11. Bignami A, Hosley M, Dahl D. Review article. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol 1993;18:419-33
12. Letourneau PC, Condic ML, Snow DM. Interactions of developing neurons with the extracellular matrix. J Neurosci 1994;14:915-28
13. Celio MR, Blümke I. Perineuronal nets - a specialized form of extracellular matrix in the adult nervous system. Brain Res Rev 1994;19:128-45
14. Ruoslahti E. Mini review. Brain extracellular matrix. Glycobiology 1996;6:489-92
15. Grumet M, Friedlander DR, Sakurai T. Functions of brain chondroitin sulfate proteoglycans during development: Interactions with adhesion molecules. Perspect on Devel Neurobiol 1996;3: 319-30
16. Brodkey JA, Gates MA, Laywell ED, Steindler DA. The complex nature of interactive neuroregeneration-related molecules. Exp Neurol 1993;123:251-70
17. Brodkey JA, Laywell ED, O'Brien TF, Faissner A, Stefansson K, Dörries HU, Schachner M, Steindler DA. Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg 1995;82:106-12
18. Feigin I. The effect of saponification on the mucopolysaccharides of the ground substance of the human brain: The relation to focal edema and multiple sclerosis. J Neuropathol Exp Neurol 1981;40: 102-11
19. Sobel RA, Mitchell ME. Fibronectin in multiple sclerosis lesions. Am J Pathol 1989;135:161-69
20. Dahl D, Perides G, Bignami A. Axonal regeneration in old multiple sclerosis plaque - immunohistochemical study with monoclonal antibodies to phosphorylated and non-phosphorylated neurofilament proteins. Acta Neuropathol 1989;79:154-59
21. Esiri MM, Morris CS. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 2. Non-neoplastic diseases. J Neurol Sci 1991;101:59-72
22. Sobel RA, Chen M, Maeda A, Hinojoza JR. Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions. J Neuropathol Exp Neurol 1995;54:202-13
23. Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system, microglial nodules and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996;55:300-309
24. Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G, Newcombe J. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution. J Neuropathol Exp Neurol 1996;55; 1194-1209
25. Sobel RA, Hinojoza JR. Endothelial cell (EC) integrin laminin (Ln) receptor expression in multiple sclerosis (MS) lesions - immunoelectron microscopy (IEM) and functional correlates [abstract]. J Neuropathol Exp Neurol 1997;56:579
26. Benveniste EN, Huneycutt BS, Shrikant P, Ballestas ME. Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system. Brain Behavior Immun 1995;9:304-14
27. Glabinski AR, Tani M, Aras S, Stoler MH, Tuohy VK, Ransohoff RM. Regulation and function of central nervous system chemokines. Int J Devel Neurosci 1995;13:153-65
28. Otten U, Gadient RA. Neurotrophins and cytokines - intermediaries between the immune and nervous systems. Int J Devel Neurosci 1995;13:147-51
29. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, Cozzolino F, Aloe L, Garaci E. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996;85:345-56
30. Sonnenberg A. Integrins and their ligands. Curr Top Microbiol Immunol 1993;184:7-35
31. Grabham PW, Goldberg DJ. Nerve growth factor stimulates the accumulation of β1 integrin at the tips of filopodia in the growth cones of sympathetic neurons. J Neurosci 1997;17:5455-5565
32. Perides G, Asher RA, Lark MW, Lane WS. Robinson RA, Bignami A. Glial hyaluronate-binding protein: A product of metalloproteinase digestion of versican? Biochem J 1995;312:377-84
33. Huffman S, Dutton SL, Ernst H, Boacle MK, Everman D, Tourkin A, Loike JD. Functional characterization of antiadhesion molecules. Perspect on Devel Neurobiol 1994;2:101-10
34. Lander AD. Proteoglycans in the nervous system. Curr Opin Neurobiol 1993;3:716-23
35. Iwata M, Carlson SS. A large chondroitin sulfate proteoglycan has the characteristics of a general extracellular matrix component of adult brain. J Neuroscience 1993;13:195-207
36. Bignami A, Perides G, Rahemtulla E Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain. J Neurosci Res 1993; 34:97-106
37. Stichel CC, Kappler J, Junghans U, Koops A, Kresse H, Müller HW. Differential expression of the small chondroitin/dermatan sulfate proteoglycans decorin and biglycan after injury of the adult rat brain. Brain Res 1995;704:263-74
38. Chiquet-Ehrismann R. Tenascins, a growing family of extracellular matrix proteins. Experientia 1995;51:853-62
39. Eddelston M, Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 1993;54:15-36
40. Pesheva P, Gloor S, Schachner M, Probstmeier R. Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism. J Neurosci 1997;17:4642-51
41. McKinnon PJ, Margolskee RF. SC1: A marker for astrocytes in the adult rodent brain is upregulated during reactive astrocytosis. Brain Res 1996;709:27-36
42. Mendis DB, Ivy GO, Brown IR. SC1, a brain extracellular matrix glycoprotein related to SPARC and follistatin, is expressed by rat cerebellar astrocytes following injury and during development. Brain Res 1996;730:95-106
43. Paulsson M. Basement membrane proteins: Structure, assembly, and cellular interactions. Crit Rev Biochem Molec Biol 1992;27: 93-127
44. Webersinke G, Bauer H, Amberger A, Zach O, Bauer HC. Comparison of gene expression of extracellular matrix molecules in brain and micro vascular endothelial cells and astrocytes. Biochem Biophys Res Comm 1992;189:877-84
45. Pákáski M, Kása P, Joó F, Wolff JR. Cerebral endothelial cell-derived laminin promotes the outgrowth of neurites in CNS neuronal cultures. Int J Dev Neurosci 1990;8:193-98
46. Romanic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 1994;4:145-56
47. Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, Gearing AJ. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview. J Neuroimmunol 1997;72:155-61
48. Giraudon P, Buart S, Bernard A, Thomasset N, Belin M-E Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotrophic virus type I (HTLV-I). Prog Neurobiol 1996;49:169-84
49. Choi BH, Suzuki M, Kim T, Wagner SL, Cunningham DD. Protease nexin-1 - localization in the human brain suggests a protective role against extravasated serine proteases. Am J Pathol 1990; 137:741-47
50. Miyamoto S, Akiyama SK, Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995;267:883-85
51. Romanic AM, Graesser D, Baron JL, Visintin I, Janeway CA, Jr, Madri JA. T cell adhesion to endothelial cells and extracellular matrix is modulated upon transendothelial cell migration. Lab Invest 1997;76:11-23
52. Notterpek LM, Rome LH. A protein involved in central nervous system myelination: Localization in the extracellular matrix and induction in neuroblastoma cells. Dev Neurosci 1994;16:267-78
53. Milner R, Edwards G, Streuli C, ffrench-Constant C. A role in migration for the αvβ1 integrin expressed on oligodendrocyte precursors. J Neurosci 1996;16:7240-52
54. Tomaselli KJ, Doherty P, Emmett CJ, Damsky CH, Walsh FS, Reichardt LF. Expression of β1 integrins in sensory neurons of the dorsal root ganglion and their functions in neurite outgrowth on two laminin isoforms. J Neurosci 1993;13:4880-88
55. Aho R, Kalimo H, Salmi M, Smith D, Jalkanen S. Binding of malignant lymphoid cells to the white matter of the human central nervous system: Role of different CD44 isoforms, β1, β2, β7 integrins, and L-selectin. J Neuropathol Exp Neurol 1997;56:557-68
56. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 1995;82:858-63
57. Kuchroo VK, Martin CA, Greer JM, Ju S-T, Sobel RA, Dorf ME. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993;151:4371-82
58. Reynolds PJ, Shimizu Y, Mobley JL. Lymphocytes and extracellular matrix. In: Shimizu Y, ed. Lymphocyte adhesion molecules. Austin: R.G. Landes Company, 1993:192-220
59. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997;159:2549-53
60. Ren Y, Savill J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing phagocytosis. J Immunol 1995;154:2366-74
61. Turley EA, Hossain MZ, Sorokan T, Jordan LM, Nagy JI. Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM. Glia 1994;12:68-80
62. Gay D, Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques. Brain 1991;114:557-72
63. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion - a quantitative MRI and electron microscopic study. Brain 1991;114:1271-80
64. Kwon EE, Prineas JW. Blood-brain barrier abnormalities in long-standing multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol 1994;53:625-36
65. Claudio L, Raine CS, Brosnan CF. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol 1995;90:228-38
66. Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J. Regulation of extravascular coagulation by microvascular permeability. Science 1985;227:1059-61
67. Koh C-S, Gausas, J, Paterson PY. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis. J Neuroimmunol 1992;38:85-94
68. Hirsch HE, Blanco CE, Parks ME. Fibrinolytic activity of plaques and white matter in multiple sclerosis. J Neuropathol Exp Neurol 1981;40:271-80
69. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993;10: 167-79
70. Trotter J, DeJong LJ, Smith ME. Opsonization with antimyelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages. J Neurochem 1986;47:779-89
71. Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 1993;143:555-64
72. Schirmer EC, Farooqui J, Polak PE, Szuchet S. GRASP: A novel heparin-binding serum glycoprotein that mediates oligodendrocyte-substratum adhesion. J Neurosci Res 1994;39:457-73
73. Cammer W, Brosnan CF, Basile C, Bloom BR, Norton WT. Complement potentiates the degradation of myelin proteins by plasmin: Implications for a mechanism of inflammatory demyelination. Brain Res 1986;364:91-101
74. Compston DAS, Morgan BP, Campbell AK, Wilkins P, Cole G, Thomas ND, Jasani B. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 1989;15:307-16
75. DeJong BA, Smith ME. A role for complement in phagocytosis of myelin. Neurochem Res 1997;22:491-98
76. Hershkoviz R, Alon R, Gilat D, Lider O. Activated T lymphocytes and macrophages secrete fibronectin which strongly supports cell adhesion. Cell Immunol 1992;141:352-61
77. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 1993;14:500-505
78. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4
79. Biddison WE, Taub DD, Cruikshank WW, Center DM, Connor EW, Honma K. Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells. J Immunol 1997;158:3046-53
80. Krieglstein K, Rufer M, Suter-Crazzolara C, Unsicker K. Neural functions of the transforming growth factors β. Int J Devel Neurosci 1995;13:301-15
81. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991;64:867-69
82. Baghdassarian D, Toru-Delbauffe D, Gavaret JM, Pierre M. Effects of transforming growth factor-β on the extracellular matrix and cytoskeleton of cultured astrocytes. Glia 1993;7:193-202
83. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β. Am J Pathol 1995;147:53-67
84. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995;45:S16-S21
85. Lotan M, Schwartz M. Cross talk between the immune system and the nervous system in response to injury: Implications for regeneration. FASEB J 1994;8:1026-33
86. Pasinetti GM, Nichols NR, Tocco G, Morgan T, Laping N, Finch CE. Transforming growth factor β1 and fibronectin messenger RNA in rat brain responses to injury and cell-type localization. Neuroscience 1993;54:893-907
87. Colton CA, Keri JE, Chen W-T, Monsky WL. Protease production by cultured microglia: Substrate gel analysis and immobilized matrix degradation. J Neurosci Res 1993;35:297-304
88. Gottschall PE, Deb S. Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons. Neuroimmunomodulation 1996;3:69-75
89. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEBJ 1994;8:385-90
90. Eddelston M, de la Torre JC, Oldstone MBA, Loskutoff DJ, Edgington TS, Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system - a role for astrocytes in cerebral hemostasis. J Clin Invest 1993;92:349-58
91. Pindon A, Hantal D, Jandrot-Perrus M, Festoff BW. Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes. Glia 1997;19:259-68
92. Gronski TJ, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 1997;272:12189-94
93. Bö L, Dawson TM, Wesselingh S, Mörk S, Choi S, Kong PA, Hanley D, Trapp BD. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brain. Ann Neurol 1994; 36:778-86
94. van der Laan LJW, Ruuls SR, Weber KS, Lodder IJ, Döpp EA, Dijkstra CD. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide. J Neuroimmunol 1996;70:145-52
95. Riedle B, Kerjaschki D. Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix. Am J Pathol 1997; 151:215-31
96. . Lider O, Cahalon L, Gilat D, Hershkoviz R, Siegel D, Margalit R, Shoseyov O, Cohen IR. A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase. Proc Natl Acad Sci USA 1995;92:5037-41
97. Hodge-Dufour J, Noble PW, Horton MR, Bao C, Wysoka M, Burdick MD, Strieter RM, Trinchieri G, Puré E. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997; 159:2492-2500
98. Fog T. On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand 1964;Supp 10:9-15
99. Powell HC, Lampert PW. Pathology of multiple sclerosis. In: Antel J, ed. Symposium on multiple sclerosis. Neurol Clin North America 1983;1(3):631-44
100. Prineas J, McDonald I. Demyelinating diseases. In: Graham, DI, Lantos PL, eds. Greenfield's neuropathology, 6th ed. New York: Oxford University Press, 1997:813-96
101. Heffner RR, Porro RS, Olson ME, Earle KE. A demyelinating disorder associated with cerebrovascular amyloid angiopathy. Arch Neurol 1976;33:501-6
102. Lefkowitz D, Angelo JN. Neuromyelitis optica with unusual vascular changes. Arch Neurol 1984;41:1103-5
103. Robinson JR, Jr, Awad IA, Zhou P, Barna BP, Estes ML. Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: Preliminary observations and working hypothesis. Neurol Res 1995;17:49-58
104. Nag S. Immunohistochemical localization of extracellular matrix proteins in cerebral vessels in chronic hypertension. J Neuropathol Exp Neurol 1996;55:381-88
105. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Berlin: Springer-Verlag; 1983:16-33
106. Hershkoviz R, Cahalon L, Gilat D, Miron S, Miller A, Lider O. Physically damaged extracellular matrix induces TNF-α secretion by interacting resting CD4+ T cells and macrophages. Scand J Immunol 1993;37:111-15
107. Raine CS. Presidential address. Multiple sclerosis: Immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 1994;53:328-37
108. Hauser IA, Setter E, Bell L, Madri JA. Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro. Am J Pathol 1993;143:173-80
109. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, Altieri DC. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993;73:1423-34
110. Gerritsen ME, Bloor CM. Endothelial cell gene expression in response to injury. FASEB J 1993;7:523-32
111. Wheatley EM, McKeown-Longo PJ, Vincent PA, Saba TM. Incorporation of fibronectin into matrix decreases TNF-induced increase in endothelial monolayer permeability. Am J Physiol 1993; 265:L148-L157
112. Shimizu Y, Shaw S. Lymphocyte interactions with extracellular matrix. FASEB J 1991;5:2292-99
113. 1-integrins in T lymphocyte migration. J Immunol 1994;153:960-71
114. Li Y-Y, Cheung HT. Basement membrane and its components on lymphocyte adhesion, migration, and proliferation. J Immunol 1992;149:3174-81
115. Hershkoviz R, Gilat D, Miron S, Mekori YA, Aderka D, Wallach D, Vlodavsky I, Cohen IR, Lider O. Extracellular matrix induces tumour necrosis factor-α secretion by an interaction between resting rat CD4+ T cells and macrophages. Immunology 1993;78: 50-57
116. 1 and E domain ligation of the leukocyte response integrin signal for different responses. J Biol Chem 1996;271:30587-94
117. Cavender DE, Edelbaum D, Welkovich L. Effects of inflammatory cytokines and phorbol esters on the adhesion of U937 cells, a human monocyte-like cell line, to endothelial cell monolayers and extracellular matrix proteins. J Leukocyte Biol 1991;49:566-78
118. Bauvois B, Rouillard D, Sanceau J, Wietzerbin J. IFN-γ and transforming growth factor-β1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J Immunol 1992;148:3912-19
119. De Nichilo MO, Burns GF. Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate αv integrin expression on cultured human macrophages. Proc Natl Acad Sci USA 1993;90:2517-21
120. Lloyd AR, Oppenheim JJ, Kelvin DJ, Taub DD. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix molecules. J Immunol 1996;156:932-38
121. Gilat D, Hershkoviz R, Mekori YA, Vlodavsky I, Lider O. Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1β. J Immunol 1994:153:4899-4906
122. 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J Immunol 1994;152:1304-13
123. Hershkoviz R, Goldkorn I, Lider O. Tumour necrosis factor-α interacts with laminin and functions as a pro-adhesive cytokine. Immunology 1995;85:125-30
124. Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. J Immunol 1996;156: 1189-95
125. Kirchheimer JC, Binder BR, Remold HG. Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue. J Immunol 1990;145:1518-22
126. Ehrlich HJ, Klein Gebbink R, Preissner KT, Keijer J, Esmon NL, Mertens K, Pannekoek H. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix. J Cell Biol 1991;115:1773-81
127. Chan BMC, Wong JGP, Rao A, Hemler ME. T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix. J Immunol 1991;147:398-404
128. 1 integrins mediate laminin/merosin binding and function as costimulatory molecules for human thymocyte proliferation. J Immunol 1995;154:500-510
129. Gilat D, Cahalon L, Hershkoviz R, Lider O. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol Today 1996;17:16-20
130. Takahashi K, Nakamura T, Adachi H, Yagita H, Okumura K. Antigen-independent T cell activation mediated by a very late activation antigen-like extracellular matrix receptor. Eur J Immunol 1991;21:1559-62
131. Sturmhöfel K, Brando C, Martinon F, Shevach EM, Coligan JE. Antigen-independent, integrin-mcdiated T cell activation. J Immunol 1995;154:2104-11
132. Naldini A, Carney DH, Bocci V, Klimpel KD, Asuncion M, Soares LE, Klimpel GR. Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 1993;147:367-77
133. Hemasath TJ, Marion LS, Stefansson K. Inhibition of T cell activation by the extracellular matrix protein tenascin. J Immunol 1994;152:5199-5207
134. Gundersen D, Trân-Thang C, Sordat B, Mourali F, Rüegg C. Plasmin-induced proteolysis of tenascin-C-modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J Immunol 1997; 158:1051-60
135. Lanir N, Ciano PS, van de Water L, McDonagh J, Dvorak AM, Dvorak HF. Macrophage migration in fibrinogen matrices. II. Effects of clotting factor XIII, fibronectin and glycosaminoglycan content on cell migration. J Immunol 1988;140:2340-49
136. low CD4+ T cells that induce experimental allergic encephalomyelitis. J Neuroimmunol 1992;40:57-70
137. Nagano N, Aoyagi M, Hirakawa K. Extracellular matrix modulates the proliferation of rat astrocytes in serum-free culture. Glia 1993;8:71-76
138. Chamak B, Mallat M. Fibronectin and laminin regulate the in vitro differentiation of microglial cells. Neuroscience 1991;45:513-27
139. Mönning U, Sandbrink R, Weidemann, Banati RB, Masters CL, Beyreuther K. Extracellular matrix influences the biogenesis of amyloid precursor protein in microglial cells. J Biol Chem 1995; 270:7104-10
140. Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J. Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 1995;15:141-51
141. Armstrong RC, Harvath L, Dubois-Dalcq ME. Type I astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 1990;27:400-407
142. Faber-Elman A, Lavie V, Schvartz I, Shaltiel S, Schwartz M. Vitronectin overrides a negative effect of TNF-α on astrocyte migration. FASEB J 1995;9:1605-13
143. Maleski M, Hockfield S. Glial cell assemble hyaluronan-based pericellular matrices in vitro. Glia 1997;20:193-202
144. Washington RA, Becher B, Balabanov R, Antel J, Dore-Duffy P. Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia. J Neurosci Res 1996;45:392-99
145. Girgrah N, Letarte M, Becker LE, Cruz TF, Theriault E, Moscarello MA. Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions of multiple sclerosis. J Neuropathol Exp Neurol 1991;50: 779-92
146. Haegel H, Tölg C, Hofmann M, Ceredig R. Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J Cell Biol 1993;122:1067-77
147. Banik NL. Pathogenesis of myelin breakdown in demyelinating diseases: Role of proteolytic enzymes. Crit Rev Neurobiol 1992; 6:257-71
148. Banati RB, Rothe G, Valet G, Kreutzberg G. Detection of lysosomal cysteine proteinases in microglia: Flow cytometric measurement and histochemical localization of cathepsin B and L. Glia 1993;7:183-91
149. Smith ME, van der Maesen K, Somera FP, Sobel RA. Effects of phorbol myristate acetate (PMA) on functions of macrophages and microglia in vitro. Neurochem Research 1998;23:431-38
150. McCarthy JB, Vachhani BV, Wahl SM, Finbloom DS, Feldman GM. Human monocyte binding to fibronectin enhances IFN-γ-induced early signaling events. J Immunol 1997;159:2424-30
151. Frisén J, Hägerstrand, Piehl F, Cullheim S, Risling M. Adhesive/ repulsive properties in the injured spinal cord: Relation to myelin phagocytosis by invading macrophages. Exp Neurol 1994;129: 183-93
152. Gates MA, Fillmore H, Steindler DA. Chondroitin sulfate proteoglycan and tenascin in the wounded adult mouse neostriatum in vitro: Dopamine neuron attachment and process outgrowth. J Neurosci 1996;16:8005-18
153. Johnson-Green PC, Dow KE, Riopelle RJ. Neunte growth modulation associated with astrocyte proteoglycans: Influence of activators of inflammation. Glia 1992;5:33-42
154. Risling M, Fried K, Lindå H, Carlstedt T, Cullheim S. Regrowth of motor axons following spinal cord lesions: Distribution of laminin and collagen in the CNS scar tissue. Brain Res Bull 1993;30: 405-14
155. Capello E, Voskuhl RR, McFarland HF, Raine CS. Multiple sclerosis: Re-expression of a developmental gene in chronic lesions correlates with remyelination. Ann Neurol 1997;41:797-805
156. Zajicek J, Compston A. Mechanisms of damage and repair in multiple sclerosis - a review. Multiple Sclerosis 1995;1:61-72
157. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993;118:283-95
158. Aloisi F, Rosa S, Testa U, Bonsi P, Russo G, Peschle C, Levi G. Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J Immunol 1994;152:5022-31
159. Gard AL, Burrell MR, Pfeiffer SE, Rudge JS, Williams WC II. Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein. Development 1995; 121:2187-95
160. Webster H deF Growth factors and myelin regeneration in multiple sclerosis. Multiple Sclerosis 1997;3:113-20
161. Milner R, Anderson HJ, Rippon RF, McKay JS, Franklin RJM, Marchionni M, Reynolds R, fFrench-Constant C. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia 1997;19:85-90
162. Malek-Hedayat S, Rome LH. Expression of a β1-related integrin by oligodendroglia in primary culture: Evidence for a functional role in myelination. J Cell Biol 1994;124:1039-46
163. Amur-Umarjee S, Schonmann V, Campagnoni AT. Neuronal regulation of myelin basic protein mRNA translocation in oligodendrocytes is mediated by platelet-derived growth factor. Devel Neurosci 1997;19:143-51
164. Frost E, Kiernan BW, Faissner A, ffrench-Constant C. Regulation of oligodendrocyte precursor migration by extracellular matrix: Evidence for substrate-specific inhibition of migration by tenascin-C. Devel Neurosci 1996;18:266-73
165. Shirazi Y, Rus HG, Macklin WB, Shin ML. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J Immunol 1993;150:4581-90
166. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-99
167. Sobel RA. The pathology of multiple sclerosis. In: Antel J, ed. Symposium on multiple sclerosis. Neurol Clin North America 1995;13:1-21
168. Müller HW, Junghans U, Kappler J. Astroglial neurotrophic and neurite-promoting factors. Pharmac Ther 1995;65:1-18
169. Choi BH. Role of the basement membrane in neurogenesis and repair of injury in the central nervous system. Microsc Res Technique 1994;28:193-203
170. Chamak B, Dobbertin A, Mallat M. Immunohistochemical detection of thrombospondin in microglia in the developing rat brain. Neuroscience 1995;69:177-87
171. Muir D. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exptl Cell Res 1994;210:243-52
172. Kannan Y, Bienenstock J, Ohta M, Stanisz, Stead RH. Nerve growth factor and cytokines mediate lymphoid tissue-induced neute outgrowth from mouse superior cervical ganglia in vitro. J Immunol 1996;157:313-20
173. Garcia-Alonso, Fetter RD, Goodman CS. Genetic analysis of Laminin A in Drosophila: Extracellular matrix containing laminin A is required for ocellar axon pathfinding. Development 1996;122: 2611-21
174. Schwab ME, Kapfhammer JP, Bandtlow CE. Inhibitors of neurite growth. Ann Rev Neurosci 1993;16:565-95
175. Johnson AR, Contact inhibition in the failure of mammalian CNS axonal regeneration. BioEssays 1993;15:807-13
176. Pindzola RR, Doller C, Silver J. Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesions. Devel Biol 1993;156:34-48
177. Fawcett J. Astrocytes and axon regeneration in the central nervous system. J Neurol 1994;241:S25-S28